Pharmaceutical composition comprising efpeglenatide as active ingredient and administration therapy thereof

MX2026007675APending Publication Date: 2026-10-02HANMI PHARM CO LTD

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MX2026007675
Authority / Receiving Office: MX · MX
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2024-12-19
Filing Date: 2026-06-18
Publication Date: 2026-10-02

Application Information

Patent Timeline

19 Dec 2024

Priority

18 Jun 2026

Application

MX2026007675

02 Oct 2026

Publication

MX2026007675A

IPC: A61P3/04; A61K38/08; A61K38/16; A61K38/17; A61K38/26; A61K45/00

CPC: A61K38/17; A61P3/04; A61K38/1796

Inventors: KIM Nayoung; HONG Sunghee

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to a pharmaceutical composition comprising efpeglenatide as an active ingredient and a method for treating obesity using same. The administration of the composition comprising efpeglenatide according to the present invention can provide a weight loss effect in obese patients without causing side effects.

Need to check novelty before this filing date? Find Prior Art